TABLE 4.
Types, names and trial attribution of drugs.
| Types | Drug names | Trial number |
|---|---|---|
| PD-1 | ||
| Toripalimab | 25 | |
| PD-1 inhibitor | 14 | |
| Camrelizumab | 13 | |
| Pembrolizumab | 13 | |
| Sintilimab | 9 | |
| Tislelizumab | 9 | |
| Nivolumab | 7 | |
| Penpulimab | 3 | |
| Spartalizumab | 2 | |
| Serplulimab | 1 | |
| PD-L1 | ||
| Avelumab | 3 | |
| Atezolizumab | 2 | |
| Durvalumab | 2 | |
| SHR-1701 | 2 | |
| Envafolimab | 1 | |
| INCB099280 | 1 | |
| INCB099318 | 1 | |
| TBQ2450 | 1 | |
| TQB2858 | 1 | |
| PD-1/CTLA-4 | ||
| Cadonilimab | 2 | |